Silver Book Fact

A statin initiation intervention aimed at Medicare Part D prescription drug plan subscribers with diabetes or coronary artery disease was successful in increasing statin use among this group of members at high risk for cardiovascular events. The estimated coronary event cost avoidance was $12,323 per 220 members who received the intervention.

Stockl, Karen M., Daniel Tjioe, Sherry Gong, Jenni Stroup, Ann S.M. Harada, and Heidi C. Lew. Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program. J Manag Care Pharm. 2008; 14(6): 532-40. http://www.amcp.org/data/jmcp/JMCPMaga_532-540.pdf

Reference

Title
Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program
Publication
J Manag Care Pharm
Publication Date
2008
Authors
Stockl, Karen M., Daniel Tjioe, Sherry Gong, Jenni Stroup, Ann S.M. Harada, and Heidi C. Lew
Volume & Issue
Volume 14, Issue 6
Pages
532-40
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A study by the Diabetes Prevention Program found that the use of the drug metformin by high-risk patients reduced the risk of development of type 2 diabetes by 31%.  
  • Laser treatments save up to $1.6 billion per year through prevention and treatment of blindness in diabetics.  
  • Medicines Reduce Complications of Diabetes: Diabetes patients treated with medicines are less likely to develop other health problems  
  • In a community pharmacy health management program called the Diabetes Ten City Challenge, in which 573 patients with diabetes participated, eye examination rates increased from 57% to 81% and foot…  
  • Anti-VEGF Visual Improvement
    Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.